DXC-023

N/A

Report date: 2025/02/13 16:05:17

Base Information

Drug NameDXC-023
Drug Alias NameDXC023DXC-023
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionProgrammed cell death protein 1 modulatorsVascular endothelial growth factor modulators
TargetsProgrammed cell death protein 1Vascular endothelial growth factor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHangzhou Dac Biotech Company Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHangzhou Dac Biotech Company Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A